Volume 51, Number 2

Rheumatic Manifestations of Gastrointestinal Diseases

Ibrahim S. Alghafeer, MD
Fellow, Division of Rheumatology 
University of Medicine and Dentistry of New Jersey 
New Brunswick, NJ 

Leonard H. Sigal, MD 
Professor and Chief, Division of Rheumatology 
University of Medicine and Dentistry of New Jersey 
New Brunswick, NJ

References

1. Wollheim FA. Enteropathic arthritis: how do the joints talk with the Gut? Curr Opin Rheumatol 2001;13:305-9.

2. Scarpa R. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel syndrome. J Rheumatol 2000;27:1241-6.

3. Picco P, Gattorno M, Marchese N, Vignola S, Sormani MP, Barabino A, Buoncompagni A. Increased gut permeability in juvenile chronic arthritides: a multivariate analysis of the diagnostic parameters. Clin Exp Rheumatol 2000;18:773-8.

4. Fresko I, Hamuryudan V, et al. Intestinal permeability in Behcet’s syndrome. Ann Rheum Dis 2001;60:65-6.

5. Salmi M, Jalkanen S. Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J Immunol 2001;66:4650-7.

6. Bargen JA. Complications and sequelae of chronic ulcerative colitis, Ann Intern Med 1929;3:335-52.

7. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore)1976;55:401-12.

8. Inman RD. Arthritis and enteritis - an interface of protean manifestations. J Rheumatol 1987;14:406-10.

9. Queiro R, et al. Subclinical sacroiliitis in inflammatory bowel disease: a clinical and follow-up study. Clin Rheumatol 2000;19:445-9.

10. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998;42:387-91.

11. Orchard TR. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 2000;118:274-8.

12. Van den Bosch F, et al. Crohn’s disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet 2000;356:1821-2.

13. Abitbol V, Roux C, Chaussade S, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995;108:417.

14. Semeao E, Jawad A, Stouffer N, et al. Risk factors for low bone mineral density in children and young adults with Crohn’s disease. J Pediatr 1999;135:593-600.

15. Haderslev KV, Tjellesen L, Sorensen HA, Staun M. Alendronate increases lumbar spine bone mineral density in patients with Crohn’s disease. Gastroenterology 2000;119:639-46.

16. Lubrano E, Ciacci C, Ames PR, et al. The arthritis of celiac disease: prevalence and pattern in 200 adult patients. Br J Rheumatol 1996;35:1314-8.

17. Usai P. Adult celiac disease is frequently associated with sacroiliitis. Dig Dis Sci 1995;40:1906-8.

18. Bagnato GF, Quattrocchi E, Gulli S, et al. Unusual polyarthritis as a unique clinical manifestation of celiac disease. Rheumatol Int 2000;20:29-30.

19. Borg AA, Dawes PT, Swan CH, Hothersall TE. Persistent monoarthritis and occult celiac disease. Postgrad Med J 1994;70:51-3.

20. Collin P, Korpela M, Hallstrom O, et al. Rheumatic complaints as a presenting symptom in patients with celiac disease. Scan J Rheumatol 1992;21:20-3.

21. Kallilorm R, Uibo O, Uibo R. Clin Rheumatol 2000;19:118-22.

22. Collin P, Reunala T, Pukkala E, et al. Celiac disease-associated disorders and survival. Gut 1994;35:1215-8.

23. McFarlane XA. Osteoporosis in treated adult celiac disease. Gut 1995;36:710-4.

24. Ratnaike RN: Whipple’s disease. Postgrad Med J 2000, 76:760-766

25. Durand DV, Lecomte C, Cathebras P, et al. Whipple disease. Clinical review of 52 cases. The SNFMI research group on Whipple disease. Medicine (Baltimore) 1997;76:170-84.

26. Puechal X. Whipple disease and arthritis. Curr Opin Rheumatol 2001;13:74-9.

27. O’Duffy JD, Griffing WL, Li CY, et al. Whipple’s arthritis: direct detection of Tropheryma whippelii in synovial fluid and tissue. Arthritis Rheum 1999;42:812-7.

28. Fantry GT, James SP. Whipple’s disease. Dig Dis 1995;13:108-18.

29. Ramaiah C. Whipple’s disease. Gastroenterol Clin North Am 1998;27:683-95.

30. Keat A. Reiter’s syndrome and reactive arthritis in perspective. N Eng J Med 1983;309:1606-12.

31. Finch W. Arthritis and the gut. Postgrad Med J 1986;86:229-34.

32. Marsal L, Winblad S, Wollheim FA. Yersinia enterocolitica arthritis in southern Sweden: a four-year follow-up study. Br Med J (Clin Res Ed) 1981;283:101-3.

33. Barth WF, Segal K: Reactive arthritis (Reiter’s syndrome). Am Fam Physician 1999;60:499-503, 507.

34. Scofield RH, et al. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet 1995;345:1542-4.

35. Pacheco-Tena C, et al. Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies. Rheumatol 2001;40:920-7.

36. Lauhio A, Leirisalo-Repo M, Lahdevirta J, et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to chlamydia arthritis. Arthritis Rheum 1991;34:6-13.

37. Creemers MC, Van Riel PL, Franssen MJ, et al. Second-line treatment in seronegative Spondyloarthropathies. Semin Arthritis Rheum 1994;24:71-81.